dc.contributor.author | Hung, C-F | en_US |
dc.contributor.author | Breen, G | en_US |
dc.contributor.author | Czamara, D | en_US |
dc.contributor.author | Corre, T | en_US |
dc.contributor.author | Wolf, C | en_US |
dc.contributor.author | Kloiber, S | en_US |
dc.contributor.author | Bergmann, S | en_US |
dc.contributor.author | Craddock, N | en_US |
dc.contributor.author | Gill, M | en_US |
dc.contributor.author | Holsboer, F | en_US |
dc.contributor.author | Jones, L | en_US |
dc.contributor.author | Jones, I | en_US |
dc.contributor.author | Korszun, A | en_US |
dc.contributor.author | Kutalik, Z | en_US |
dc.contributor.author | Lucae, S | en_US |
dc.contributor.author | Maier, W | en_US |
dc.contributor.author | Mors, O | en_US |
dc.contributor.author | Owen, MJ | en_US |
dc.contributor.author | Rice, J | en_US |
dc.contributor.author | Rietschel, M | en_US |
dc.contributor.author | Uher, R | en_US |
dc.contributor.author | Vollenweider, P | en_US |
dc.contributor.author | Waeber, G | en_US |
dc.contributor.author | Craig, IW | en_US |
dc.contributor.author | Farmer, AE | en_US |
dc.contributor.author | Lewis, CM | en_US |
dc.contributor.author | Mueller-Myhsok, B | en_US |
dc.contributor.author | Preisig, M | en_US |
dc.contributor.author | McGuffin, P | en_US |
dc.contributor.author | Rivera, M | en_US |
dc.date.accessioned | 2015-06-01T16:01:09Z | |
dc.date.available | 2015-03-24 | en_US |
dc.date.issued | 2015-04-17 | en_US |
dc.identifier.issn | 1741-7015 | en_US |
dc.identifier.other | 10.1186/s12916-015-0334-3 | |
dc.identifier.other | ARTN 86 | en_US |
dc.identifier.other | ARTN 86 | en_US |
dc.identifier.other | ARTN 86 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/7548 | |
dc.description.sponsorship | . This study was
funded by the Medical Research Council, UK. GlaxoSmithKline (G0701420)
funded the DeNT study and were co-funders with the Medical Research
Centre for the GWAS of the whole sample. The GENDEP study was funded
by a European Commission Framework 6 grant, EC Contract Ref.: LSHB-CT-
2003-503428. This study presents independent research [part-] funded by
the National Institute for Health Research (NIHR) Biomedical Research
Centre at South London and Maudsley NHS Foundation Trust and King’s
College London | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BMC MEDICINE | en_US |
dc.subject | Body mass index | en_US |
dc.subject | Genetic risk score | en_US |
dc.subject | Major depressive disorder | en_US |
dc.subject | Obesity | en_US |
dc.title | A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1186/s12916-015-0334-3 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000353257600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 13 | en_US |